Literature DB >> 9086865

Does preference for type of treatment matter? A study of exposure in vivo with or without hypnosis in the treatment of panic disorder with agoraphobia.

R Van Dyck1, P Spinhoven.   

Abstract

There is evidence that preference for a given therapy may influence results. Literature also suggests that hypnotizability may be elevated in agoraphobic patients, making hypnosis a potentially powerful method for treatment. Agoraphobic patients (N = 64) were treated with either exposure in vivo or exposure combined with hypnosis in a crossover design. Half of the patients started with the treatment they preferred and the other half received the other treatment first. Although patients' preference clearly shifted in favor of the combined therapy in the course of the study, no effect of preference on outcome was evident. Although hypnotizability clearly correlated to outcome in the combined therapy, no difference in effect between the two therapies was found on behavioral, self-report, and observer measures. No additional effect of hypnosis could be shown and preference was not found to be a powerful mediator of effect.

Entities:  

Mesh:

Year:  1997        PMID: 9086865     DOI: 10.1177/01454455970212003

Source DB:  PubMed          Journal:  Behav Modif        ISSN: 0145-4455


  3 in total

1.  Client preferences affect treatment satisfaction, completion, and clinical outcome: a meta-analysis.

Authors:  Oliver Lindhiem; Charles B Bennett; Christopher J Trentacosta; Caitlin McLear
Journal:  Clin Psychol Rev       Date:  2014-06-16

2.  The impact of hypnotic suggestibility in clinical care settings.

Authors:  Guy H Montgomery; Julie B Schnur; Daniel David
Journal:  Int J Clin Exp Hypn       Date:  2011-07

3.  Treatment modality preferences and adherence to group treatment for panic disorder with agoraphobia.

Authors:  Michel Perreault; Dominic Julien; Noé Djawn White; Claude Bélanger; André Marchand; Theodora Katerelos; Diana Milton
Journal:  Psychiatr Q       Date:  2014-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.